Serum Institute to start Covid-19 vaccine trials on 7-11 YO
SI made vaccine Covishield has already been administered to over 870 mn adults.
Trial of the vaccine onn 12-17 YO is already being conducted and is reportedly safe to be administered.
The Indian government has allowed Serum Institute to conduct Covid-19 vaccine trials on children in the age group of 7-11 years.
Covishield has already been administered to more than 870 million adults in India. The subject expert panel said that the drug regulator has allowed SI to conduct trials on 7-11 year old after detailed deliberation.
Trials are already going on for children between 12-17 years of age and have reportedly proved to be successful.
It may be noted that so far only ZyCoV-D has received emergency use approval among adults and children above the age of 12 years in India.
